|
AZIN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.51380000043855E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75350001185848E-09 |
| Normal-vs-Stage2 |
1.013920E-04 |
| Normal-vs-Stage3 |
9.929600E-02 |
| Normal-vs-Stage4 |
9.373000E-01 |
| Stage1-vs-Stage2 |
2.852800E-01 |
| Stage1-vs-Stage3 |
5.210200E-04 |
| Stage1-vs-Stage4 |
6.659600E-02 |
| Stage2-vs-Stage3 |
7.392300E-02 |
| Stage2-vs-Stage4 |
1.418420E-01 |
| Stage3-vs-Stage4 |
4.203600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.235600000151E-07 |
| Normal-vs-AfricanAmerican |
1.71458000000069E-05 |
| Normal-vs-Asian |
4.266000E-01 |
| Caucasian-vs-AfricanAmerican |
9.733600E-01 |
| Caucasian-vs-Asian |
2.061800E-01 |
| AfricanAmerican-vs-Asian |
1.442230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.03140001778735E-09 |
| Normal-vs-Female |
7.443900E-02 |
| Male-vs-Female |
4.442100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.022490E-03 |
| Normal-vs-Extreme_Weight |
1.9204999812672E-09 |
| Normal-vs-Obese |
3.200800E-04 |
| Normal-vs-Extreme_Obese |
2.26199999999732E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.476050E-01 |
| Normal_Weight-vs-Obese |
7.904400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.518000E-01 |
| Extreme_Weight-vs-Obese |
2.949900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.546000E-01 |
| Obese-vs-Extreme_Obese |
1.396160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.647000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.91290000000266E-05 |
| Normal-vs-Age(61-80Yrs) |
2.43229999474792E-08 |
| Normal-vs-Age(81-100Yrs) |
1.28479999994546E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.034500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.571750E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.657700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.219420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.708390E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.812040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.72269976062012E-10 |
| Normal-VS-Type2 PRCC |
2.834100E-04 |
| Normal-VS-KIRP CIMP |
4.608300E-02 |
| Normal-VS-Unclassified PRCC |
1.171950E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.383700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.659140E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.651600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.997700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.024000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.335900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07239999605591E-08 |
| Normal-vs-N1 |
4.037400E-01 |
| Normal-vs-N2 |
5.518600E-01 |
| N0-vs-N1 |
1.178290E-03 |
| N0-vs-N2 |
2.183800E-01 |
| N1-vs-N2 |
6.460200E-01 |
|
|
